Mammoth Biosciences

Mammoth Biosciences

Mammoth Biosciences

The world's first CRISPRenabled platform for disease detection.
Founded
2017
Raised
$68M
Follow us
Alexa global traffic share
Twitter followers
30 Jan 2020
$45,000,000
Venture capital (Series B)

Mammoth Biosciences Raises $45M in Series B Funding Round

FinSMEs
+1
01 Aug 2018
$23,000,000
Venture capital (Series A)
NFX Guild, 8VC, Mayfield

CRISPR-Based Disease Detection Platform Mammoth Biosciences Raises $23M

FinSMEs
+1